Solvents in the Workplace: Health Effects, WES Values and Exposure Control in Australia

The Pervasive Challenge of Solvent Exposure

Organic solvents are among the most widely used industrial chemicals in Australia. They are used for cleaning, degreasing, thinning, extraction, and as reactive intermediates in chemical synthesis. Industries with significant solvent use include automotive repair and refinishing, printing and publishing, dry cleaning, shoe manufacturing, furniture production, surface coating, electronics manufacturing, and laboratory work.

Despite their ubiquity, solvents are often underestimated as occupational health hazards. Their volatility makes inhalation exposure almost inevitable in poorly ventilated spaces, and many solvents are also readily absorbed through intact skin — a route of exposure not captured by air monitoring alone. The health effects range from acute intoxication (narcosis, dizziness, loss of consciousness) to serious chronic disease including peripheral neuropathy, liver damage, kidney toxicity, reproductive effects, and cancer.

Classification of Occupational Solvents

Solvents can be classified by chemical family, which broadly predicts their health effects and appropriate control measures:

• Aliphatic hydrocarbons (hexane, heptane, mineral spirits): Central nervous system (CNS) depression; n-hexane specifically causes peripheral neuropathy via its metabolite 2,5-hexanedione.
• Aromatic hydrocarbons (benzene, toluene, xylene, styrene): CNS depression, with benzene being a confirmed human carcinogen (leukaemia). Toluene is toxic to the developing fetus and causes reproductive effects.
• Halogenated solvents (trichloroethylene, methylene chloride, perchloroethylene): CNS depression, liver toxicity, kidney toxicity. Trichloroethylene and methylene chloride are Group 1 IARC carcinogens.
• Ketones (acetone, MEK, MIBK, cyclohexanone): CNS depression; MEK potentiates the peripheral neuropathy of n-hexane. Generally lower toxicity than aromatics or halogenated solvents.
• Alcohols (methanol, isopropanol, ethanol, n-butanol): CNS depression; methanol specifically causes optic nerve damage and blindness at toxic doses.
• Glycol ethers (2-ethoxyethanol, 2-methoxyethanol, EGBE): Reproductive toxicity (testicular damage, embryotoxicity) is the primary concern. Readily absorbed through skin.
• Esters (ethyl acetate, butyl acetate): Generally mild CNS depression and irritation; lower chronic toxicity than most other solvent classes.

Key Australian WES Values for Common Solvents

The following Workplace Exposure Standards (WES-TWA over 8 hours) apply in Australia for common solvents. Note that skin notation (Sk) indicates significant skin absorption potential:

• Benzene: 1 ppm (Sk) — carcinogen, no safe threshold. Lowest possible exposure is the goal.
• Toluene: 50 ppm (Sk) — reproductive hazard
• Xylene (all isomers): 80 ppm (Sk)
• Styrene: 20 ppm (Sk)
• n-Hexane: 20 ppm — peripheral neuropathy hazard
• Trichloroethylene: 10 ppm (Sk) — carcinogen
• Perchloroethylene (tetrachloroethylene): 25 ppm (Sk) — possible carcinogen
• Methylene chloride (DCM): 50 ppm — carcinogen
• Acetone: 500 ppm
• Isopropanol: 200 ppm (Sk)
• MEK (methyl ethyl ketone): 150 ppm (Sk)
• 2-Ethoxyethanol: 5 ppm (Sk) — reproductive hazard
• 2-Methoxyethanol: 0.5 ppm (Sk) — reproductive hazard

The “(Sk)” notation is critical — it means that skin absorption makes a significant contribution to overall body burden. Where skin contact occurs, air monitoring alone will underestimate exposure, and biological monitoring (urinary metabolite measurement) should be used instead of or in addition to air monitoring.

Biological Monitoring for Solvent Exposure

Biological monitoring (biological effect monitoring) measures the concentration of a solvent or its metabolites in biological fluids (blood, urine, exhaled air) to assess actual body burden, regardless of the route of exposure. Biological Exposure Indices (BEIs) or Biological Monitoring Guidance Values (BMGVs) are used to interpret results.

Key biological monitoring tests for common solvents include:

• Benzene: Urinary S-phenylmercapturic acid and t,t-muconic acid (end of shift)
• Toluene: Urinary o-cresol and hippuric acid (end of shift); blood toluene
• Xylene: Urinary methylhippuric acid (end of shift)
• n-Hexane: Urinary 2,5-hexanedione (end of shift)
• Styrene: Urinary mandelic acid and phenylglyoxylic acid (end of shift)
• Trichloroethylene: Urinary trichloroacetic acid and total trichlorocompounds (end of week)
• MEK: Urinary MEK (end of shift)

Biological monitoring requires a chain of custody for samples, NATA-accredited laboratory analysis, and interpretation by a qualified occupational hygienist or occupational physician. Sample timing is critical — most solvent metabolites must be measured at the end of shift or end of working week to accurately reflect that day’s/week’s exposure.

Special Hazard: Benzene

Benzene deserves special attention as a Group 1 IARC carcinogen with no demonstrated safe threshold. It causes aplastic anaemia at high doses and leukaemia (particularly acute myeloid leukaemia) following chronic lower-level exposure. The Australian WES-TWA of 1 ppm reflects an attempt to balance the economic importance of benzene-using industries with the recognition that any benzene exposure carries some risk.

Industries with significant benzene exposure in Australia include petroleum refining, service station work, coke oven operations, and some chemical manufacturing processes. Benzene is also a component of petrol (regulated at ≤1% by volume in Australia). Workers exposed to benzene should be in a formal health surveillance program including periodic blood counts.

The upcoming WES to WEL transition may result in a further reduction of the benzene WEL from 1 ppm, consistent with international trends (the UK WEL is 1 ppm; the US NIOSH REL is 0.1 ppm; ACGIH TLV is 0.5 ppm as a suspected carcinogen with no practical safe level).

Engineering Controls for Solvent Exposure

The hierarchy of controls should guide solvent management:

Substitution

The most effective control is substituting a hazardous solvent with a safer alternative:

• Water-based formulations replacing solvent-based products (paints, adhesives, cleaners)
• Less hazardous glycol ethers (EGBE) replacing reproductive toxicants (2-methoxyethanol)
• D-limonene (derived from citrus) as a substitute for mineral spirits in some degreasing applications
• Aqueous ultrasonic cleaning replacing solvent degreasing

Engineering Controls

• Local exhaust ventilation (LEV): Capturing solvent vapours at source before they disperse into the workroom
• Enclosed systems: Closed-loop dispensing and recovery systems, particularly for high-volume solvent use
• General dilution ventilation: Where LEV is impractical, general ventilation can reduce bulk-air solvent concentrations but is less effective than LEV for point-source emissions
• Refrigerated solvent baths: Reducing vapour pressure by operating cold-cleaning tanks at lower temperatures

PPE

Solvent-resistant gloves are critical where skin contact occurs. Note that different glove materials offer different protection against different solvents: butyl rubber is generally superior for ketones and esters; nitrile provides reasonable protection for many hydrocarbons; neoprene offers broad-spectrum protection. Latex provides minimal protection against most organic solvents.

Respiratory protection (organic vapour cartridges) is required where engineering controls cannot reduce inhalation exposure below the WES.

Frequently Asked Questions

My workers complain of headaches and dizziness at the end of the shift — could this be solvent exposure?

Yes. CNS depression from solvent inhalation is characterised by headache, dizziness, fatigue, poor concentration, and mild euphoria — often described as feeling “drunk.” These symptoms during work and resolution after leaving the exposure environment is a classic pattern of solvent overexposure. This warrants an urgent exposure assessment and review of ventilation controls.

Do water-based paints eliminate all solvent exposure?

No. Many water-based formulations contain significant concentrations of glycol ethers, alcohols, and other co-solvents. While they generally eliminate aromatic hydrocarbon exposure, the co-solvents may introduce different hazards. Always check the SDS for all ingredients, not just the water-based designation.

Are solvent exposure effects reversible?

It depends on the solvent and the severity and duration of exposure. CNS effects from acute overexposure generally resolve after removal from exposure. Peripheral neuropathy from n-hexane may partially recover over months to years, but severe cases leave permanent disability. Benzene-induced leukaemia is obviously not reversible. Prevention is far preferable to treatment.